Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data

Del Prato S.; Nauck M.; Duran-Garcia S.; Maffei L.; Rohwedder K.; Theuerkauf A.; Parikh S.

首页> 外文期刊>Diabetes, obesity & metabolism >Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data

【24h】

Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data

机译：达格列净与磺脲类作为二甲双胍的辅助治疗在2型糖尿病患者中的长期血糖反应和耐受性：4年数据

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aims: To assess the long-term efficacy and tolerability of dapagliflozin versus glipizide as add-on to metformin in patients with inadequately controlled type 2 diabetes.

机译：目的：评估达格列净与格列吡嗪作为二甲双胍的补充药物在2型糖尿病控制不足的患者中的长期疗效和耐受性。

著录项

来源
《Diabetes, obesity & metabolism》 |2015年第6期|共10页
作者
Del Prato S.; Nauck M.; Duran-Garcia S.; Maffei L.; Rohwedder K.; Theuerkauf A.; Parikh S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词
dapagliflozin; durability; efficacy; safety; SGLT2 inhibitor; type 2 diabetes;

机译：达格列净;持久性;疗效;安全性;SGLT2抑制剂;2型糖尿病;

相似文献

外文文献
中文文献
专利

1. Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data [J] . Del Prato S., Nauck M., Duran-Garcia S., Diabetes, obesity & metabolism . 2015,第6期

机译：达格列净与磺脲类作为二甲双胍的辅助治疗在2型糖尿病患者中的长期血糖反应和耐受性：4年数据
2. Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: A randomized, 52-week, double-blind, active-controlled noninferiority trial [Vergleich von Dapagliflozin und Glipizid als Add-on-Therapie bei Typ-2-Diabetikern mit unzureichender Blutzuckerkontrolle unter Metformin: Eine randomisierte, doppelblinde, verumkontrollierte Nichtunterlegenheitsstudie über 52 Wochen] [J] . NauckM., DelPratoS., MeierJ.J., DMW: Deutsche Medizinische Wochenschrift . 2013,第S1期

机译：Dapagliflozin与glipizide联合治疗对二甲双胍血糖控制不足的2型糖尿病患者：一项随机，为期52周，双盲，主动控制的非劣效性试验[dapagliflozin和glipizide作为附加治疗的比较血糖控制不佳的二型糖尿病患者服用二甲双胍：一项52周的随机，双盲，经血清控制的非劣效性研究]
3. Durability and tolerability of dapagliflozin over 52 weeks as add-on to metformin and sulphonylurea in type 2 diabetes [J] . Matthaei S., Bowering K., Rohwedder K., Diabetes, obesity & metabolism . 2015,第11期

机译：达格列净在2型糖尿病中作为二甲双胍和磺脲类药物的补充品，在52周内具有持久性和耐受性
4. The precision of identified variables with respect to multivariable set size in glycaemic data from a virtual type 1 diabetic patient [C] . Erin J. Mansell, Paul D. Docherty, J. Geoffery Chase IFAC Symposium on Biological and Medical Systems . 2016

机译：来自虚拟1型糖尿病患者的血糖数据中鉴定变量的精度相对于血糖数据中的多变量尺寸
5. Feasibility Study of a Randomized Controlled Trial Protocol to Examine the Effectiveness of Auriculotherapy (AT) in Improving Sleep Condition and Glycaemic Control in Clients with Type 2 Diabetes. [D] . Kwan, Yee Mei. 2013

机译：一项随机对照试验方案的可行性研究，以检查耳穴疗法（AT）改善2型糖尿病患者睡眠状况和血糖控制的有效性。
6. Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin [O] . Michael A. Nauck, Stefano Del Prato, Juris J. Meier, 2011

机译：达格列净与格列吡嗪相比二甲双胍的血糖控制不足的2型糖尿病患者可作为附加疗法
7. Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data [O] . Del Prato S, Nauck M., Durán-Garcia S., 2015

机译：达格列净与磺脲类作为二甲双胍的补充疗法在2型糖尿病患者中的长期血糖反应和耐受性：4年数据

Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data

摘要

著录项

相似文献

相关主题

期刊订阅